TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33422947

Group type: EXPERIMENTAL
Intervention: Butylphthalide
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-butylphthalide
Number of subjects: 64
Study: 35387669

Group type: EXPERIMENTAL
Intervention: Text message-based intervention for 7 consecutive nights
Number of subjects: 50
Study: 34518459

Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg with/without dose titration (10 mg/day escalated to 23 mg)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: No dose titration
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Dose titration
Number of subjects: 160
Study: 35762420

Group type: EXPERIMENTAL
Intervention: Methylseleninic acid (MSeA) at 3 ppm selenium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Se-methylselenocysteine (MSeC) at 3 ppm selenium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet (no selenium supplementation)
Number of subjects: 0
Study: 32757324

Group type: EXPERIMENTAL
Intervention: Selective retina therapy (SRT) with a wavelength of 527 nm
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Selective retina therapy (SRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untreated eyes
Number of subjects: 20
Study: 35509694

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (30-min sessions, 3 times a week for 5 weeks)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (relaxation for 30 min, 3 times a week for 5 weeks)
Number of subjects: 74
Study: 33180985

Group type: EXPERIMENTAL
Intervention: Preventive treatment with vigabatrin
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional treatment with vigabatrin
Number of subjects: 94
Study: 34548243

Group type: EXPERIMENTAL
Intervention: Camelina sativa oil (CSO) providing 10 g/d ALA
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Fatty fish (FF) providing 4 fish meals/week
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Lean fish (LF) providing 4 fish meals/week
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control diet limiting fish and ALA intake
Number of subjects: 79
Study: 34841917

Group type: EXPERIMENTAL
Intervention: WiiNWalk intervention (modified Wii Fit activities for prosthetic rehabilitation)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Attention control group (Big Brain Academy: Wii Degree)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: WiiNWalk intervention
Number of subjects: 71
Study: 32350110

Group type: EXPERIMENTAL
Intervention: pAKT1T308
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pAKT1T308 + pAKT1S473
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ser‐473 phosphorylation
Number of subjects: 0
Study: 36062316

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 16552

Group type: COMPARATOR
Intervention: Fecal immunochemical test (FIT)
Number of subjects: 16552

Group type: EXPERIMENTAL
Intervention: Colonoscopy with withdrawal time ≥ 6 min
Number of subjects: 16552

Group type: EXPERIMENTAL
Intervention: Antispasmodic use during colonoscopy
Number of subjects: 16552

Group type: EXPERIMENTAL
Intervention: Colonoscopy with insertion time > 20 min
Number of subjects: 16552
Study: 32419304

Group type: EXPERIMENTAL
Intervention: PF-06651600 (200 mg once daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 34558485

Group type: EXPERIMENTAL
Intervention: Laser acupuncture with psychological counseling
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Laser acupuncture
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Psychological counseling
Number of subjects: 150
Study: 33234648

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1 μg/kg/hour continuous infusion starting on the day of operation until 08:00 on postoperative day 1)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Placebo (normal saline administered at the same rate as dexmedetomidine)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 700

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 700
Study: 33148016

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/d
Number of subjects: 8179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8179
Study: 35392827

Group type: EXPERIMENTAL
Intervention: ACP Video Program
Number of subjects: 6117

Group type: COMPARATOR
Intervention: Usual ACP practices (Control)
Number of subjects: 6117
Study: 32372663

Group type: EXPERIMENTAL
Intervention: Bronchoscopic brushing and TBNA for lung adenocarcinoma diagnosis
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control group of benign lung diseases
Number of subjects: 276
Study: 35130109

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus CNCM I-3690
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (acidified milk)
Number of subjects: 92
Study: 33823833

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Software-based intervention
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Web and Software groups
Number of subjects: 225
Study: 36129881

Group type: EXPERIMENTAL
Intervention: Gait retraining intervention (6 weeks of training)
Number of subjects: 40
Study: 34049690

Group type: EXPERIMENTAL
Intervention: Dilation group
Number of subjects: 49

Group type: COMPARATOR
Intervention: Non-dilation group
Number of subjects: 49
Study: 32543677

Group type: EXPERIMENTAL
Intervention: Physician notification for colorectal cancer screening (patient-specific reminders)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic reminders (general information about regional screening adherence)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (no reminders)
Number of subjects: 0
Study: 32064530

Group type: EXPERIMENTAL
Intervention: Generativity intervention (writing about life experiences and sharing advice with others)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control condition (writing about neutral topics)
Number of subjects: 73
Study: 33634488

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation + Nature Sounds (PMR + NS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (routine teaching procedure)
Number of subjects: 0
Study: 35398870

Group type: EXPERIMENTAL
Intervention: Technology-based psychosocial education and counseling program
Number of subjects: 55
Study: 33431344

Group type: EXPERIMENTAL
Intervention: 8-week low energy diet (LED)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Pre-LED levels of IGF-II and IGF2R
Number of subjects: 223
Study: 32928277

Group type: EXPERIMENTAL
Intervention: Online intervention program (HEP-S) for 20 weeks
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Enhanced online intervention program (HEP-S with gamification) for 20 weeks
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard control group with no intervention
Number of subjects: 600
Study: 35361442

Group type: EXPERIMENTAL
Intervention: HIIT exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: n-3 FA supplementation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (olive oil 1.6 g daily)
Number of subjects: 80
Study: 33250284

Group type: EXPERIMENTAL
Intervention: Single‐sided locking STS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pulvertaft
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Double‐sided nonlocking STS
Number of subjects: 24
Study: 35101083

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1 g intravenous bolus at the start and at the end of surgery
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Hypotension-avoidance strategy
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Hypertension-avoidance strategy
Number of subjects: 10000
Study: 33543867

Group type: EXPERIMENTAL
Intervention: Sugammadex as primary reversal agent
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Sugammadex exclusively
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Sugammadex use among practitioners with ≤5 years of practice
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Sugammadex use after controlling for institutional restriction and practice type
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Assessment of NMB (train-of-four)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Assessment of NMB among anesthesiologists using sugammadex
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Use of sugammadex for pediatric postmenarchal girls
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Discussion of sugammadex effects on hormonal contraception
Number of subjects: 419
Study: 32179258

Group type: EXPERIMENTAL
Intervention: QFR-guided strategy
Number of subjects: 3830

Group type: COMPARATOR
Intervention: Angiography-guided strategy
Number of subjects: 3830
Study: 34924251

Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Land-based Exercise (LBE)
Number of subjects: 30
Study: 34267349

Group type: EXPERIMENTAL
Intervention: I-P-R-F vaccine
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 33031329

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study: 33310384

Group type: EXPERIMENTAL
Intervention: Indirect questioning technique
Number of subjects: 581

Group type: COMPARATOR
Intervention: Direct questioning technique
Number of subjects: 581
Study: 33009815

Group type: EXPERIMENTAL
Intervention: 6.8 mg Neuropeptide Y (NPY)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 36328045

Group type: EXPERIMENTAL
Intervention: Routine change of gloves and instruments before wound closure
Number of subjects: 13301

Group type: COMPARATOR
Intervention: Current practice (no routine change of gloves and instruments)
Number of subjects: 13301
Study: 34297114

Group type: EXPERIMENTAL
Intervention: Perceived concept of sexual harassment (touching body)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Perceived uncomfortable behaviors by the assault
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Frequency of sexual harassment among urban students
Number of subjects: 976

Group type: COMPARATOR
Intervention: Frequency of sexual harassment among rural students
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Main motives for harassment (absence of sanctions)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Reasons for harassment (absence of punishment)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Reasons for harassment (wrong concepts about women)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Main reaction to harassment (feeling bad and wishing to act)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Main reaction to harassment (feeling bad but helpless)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Reported taking proper action against harassment
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Experience of harassment (urban students)
Number of subjects: 976

Group type: COMPARATOR
Intervention: Experience of harassment (rural students)
Number of subjects: 976
Study: 33980168

Group type: EXPERIMENTAL
Intervention: Weekly befriending for 4 months from a trained volunteer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 32379383

Group type: EXPERIMENTAL
Intervention: Short Sleep (6.5 hr sleep opportunity)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Healthy Sleep (9.5 hr sleep opportunity)
Number of subjects: 88
Study: 32295605

Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR) programme
Number of subjects: 272
Study: 35355200

Group type: EXPERIMENTAL
Intervention: Robotic-assisted incisional hernia repair (RVIHR)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Laparoscopic incisional hernia repair (LVIHR)
Number of subjects: 37
Study: 33908635

Group type: EXPERIMENTAL
Intervention: Riluzole, a benzothiazole sodium channel blocker, dosage and duration not specified.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Population pharmacokinetic model for riluzole incorporating time‐dependent clearance and volume of distribution.
Number of subjects: 0
Study: 32708292

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 80

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups (Dabigatran, Rivaroxaban, Apixaban, Warfarin)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori presence
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs) use
Number of subjects: 80
Study: 36244997

Group type: EXPERIMENTAL
Intervention: Glar/Exenatide
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Glar/Lispro
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Glar
Number of subjects: 102
Study: 33720350

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg once daily for 7 days
Number of subjects: 726

Group type: COMPARATOR
Intervention: Linezolid 600 mg every 12 hours for 10 days
Number of subjects: 726
Study: 32344841

Group type: EXPERIMENTAL
Intervention: 2 × 8 hour shifts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Being a duty officer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not working the day before the accident
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distance between home and work >3.6 to 9 km
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distance between home and work >9 km to 19 km
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distance between home and work >19 km
Number of subjects: 0
Study: 36397349

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study: 32223724

Group type: EXPERIMENTAL
Intervention: Zephyr Valve
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 190
Study: 35138505

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan (SV)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Valsartan (V)
Number of subjects: 143
Study: 33225399

Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Lactobacillus casei Zhang, Lactobacillus plantarum P‐8, and Bifdobacterium animalis subsp. lactis V9) for 28 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (routine regimen without probiotics)
Number of subjects: 45
Study: 36432479

Group type: EXPERIMENTAL
Intervention: Acidified milk
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Yogurt
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-dairy meal
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Milk fermentation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Milk and yogurt
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cheese
Number of subjects: 14
Study: 32917410

Group type: EXPERIMENTAL
Intervention: Cemiplimab 3 mg/kg intravenously every 2 weeks for 48 weeks (monotherapy cohort)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cemiplimab 3 mg/kg intravenously every 2 weeks for 48 weeks with hypofractionated radiation therapy (hfRT) during week 2 (combination cohort)
Number of subjects: 20

Group type: COMPARATOR
Intervention: PD-L1 protein expression
Number of subjects: 20

Group type: COMPARATOR
Intervention: PD-L1 mRNA levels
Number of subjects: 20
Study: 35675940

Group type: EXPERIMENTAL
Intervention: Bupivacaine injection after PRF ablation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Normal saline injection after PRF ablation
Number of subjects: 73
Study: 33159822

Group type: EXPERIMENTAL
Intervention: SAMBA I VL testing
Number of subjects: 60889
Study: 36102962

Group type: EXPERIMENTAL
Intervention: C4d-positive group
Number of subjects: 65

Group type: COMPARATOR
Intervention: C4d-negative group
Number of subjects: 65
Study: 34664294

Group type: EXPERIMENTAL
Intervention: delmopinol
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: chlorhexidine (CHX)
Number of subjects: 89

Group type: COMPARATOR
Intervention: placebo mouthrinse
Number of subjects: 89
Study: 35908869

Group type: EXPERIMENTAL
Intervention: V114 (15-valent pneumococcal conjugate vaccine)
Number of subjects: 245

Group type: COMPARATOR
Intervention: PCV13 (13-valent pneumococcal conjugate vaccine)
Number of subjects: 245
Study: 36175271

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Health and Wellness Education (HEW)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both TCC and HEW
Number of subjects: 170
Study: 33588808

Group type: EXPERIMENTAL
Intervention: 12-month distance-learning curriculum adapted from Cooking Matters®
Number of subjects: 165
Study: 32690521

Group type: EXPERIMENTAL
Intervention: Custom foot orthoses made using a direct adaptation technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Custom foot orthoses made through a digital design and production process
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prefabricated orthoses
Number of subjects: 0

Group type: COMPARATOR
Intervention: All interventions (custom FO and prefabricated orthoses)
Number of subjects: 0
Study: 35337692

Group type: EXPERIMENTAL
Intervention: Letrozole-palbociclib
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (chemotherapy)
Number of subjects: 106
Study: 33605108

Group type: EXPERIMENTAL
Intervention: Convalescent Plasma with Tocilizumab (CPT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Convalescent Plasma (CP)
Number of subjects: 110
Study: 33172094

Group type: EXPERIMENTAL
Intervention: Foodbot Factory
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control app
Number of subjects: 73
Study: 33991341

Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg (weeks 0, 4, and 16)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fumaric acid esters (FAEs) (30 mg daily up to 720 mg daily)
Number of subjects: 120
Study: 34678593

Group type: EXPERIMENTAL
Intervention: Spironolactone treatment
Number of subjects: 0
Study: 33423762

Group type: EXPERIMENTAL
Intervention: Quilting sutures
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sponge nasal packing
Number of subjects: 76
Study: 32086016

Group type: EXPERIMENTAL
Intervention: Subsidized pour-flush latrine to septic tank system
Number of subjects: 517

Group type: COMPARATOR
Intervention: Control compounds (existing shared latrines)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Intervention compounds (hygienic emptying)
Number of subjects: 517
Study: 32985280

Group type: EXPERIMENTAL
Intervention: Probiotics (500 mg daily for 10 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (daily for 10 weeks)
Number of subjects: 52
Study: 32926760

Group type: EXPERIMENTAL
Intervention: Concurrent treatment (RT delivered on the same day as or in between doses of ICT)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Nonconcurrent treatment (RT not delivered on the same day as ICT)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Concurrent treatment
Number of subjects: 199
Study: 33859685

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (0.4 mg/kg continuous infusion over 20 min)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 60
Study: 34280047

Group type: EXPERIMENTAL
Intervention: 3-dimensional computed tomography tutorial
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2-dimensional computed tomography tutorial
Number of subjects: 0
Study: 32220072

Group type: EXPERIMENTAL
Intervention: Radiologically defined sarcopenia
Number of subjects: 2181
Study: 34333487

Group type: EXPERIMENTAL
Intervention: Clear Speech (CS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Habitual Speech (HS)
Number of subjects: 31
Study: 33151438

Group type: EXPERIMENTAL
Intervention: Static stretching at 120% intensity
Number of subjects: 23

Group type: COMPARATOR
Intervention: Static stretching at 100% intensity
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both groups (100% and 120% intensity)
Number of subjects: 23
Study: 35474116

Group type: EXPERIMENTAL
Intervention: Workout on Wheels internet intervention (WOWii)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 168
Study: 33882059

Group type: EXPERIMENTAL
Intervention: Midwifery continuity of care (POPPIE group)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Standard maternity care (Control group)
Number of subjects: 334
Study: 35140781

Group type: EXPERIMENTAL
Intervention: 2 mA TI stimulation for 20 minutes
Number of subjects: 40

Group type: COMPARATOR
Intervention: tDCS for 20 minutes
Number of subjects: 40
Study: 33744981

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (IVB)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Laser photocoagulation
Number of subjects: 26
Study: 32432388

Group type: EXPERIMENTAL
Intervention: Lorecivivint 0.07 mg
Number of subjects: 455

Group type: COMPARATOR
Intervention: Lorecivivint 0.03 mg
Number of subjects: 455

Group type: COMPARATOR
Intervention: Lorecivivint 0.23 mg
Number of subjects: 455

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 455
Study: 36386125

Group type: EXPERIMENTAL
Intervention: Xinbao pill (XBP)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Conventional drug therapy combined with placebo
Number of subjects: 284
Study: 34959963

Group type: EXPERIMENTAL
Intervention: Goji berries (28 g, five times weekly for 90 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (supplement containing 6 mg L and 4 mg Z, five times weekly for 90 days)
Number of subjects: 27
Study: 33408472

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 166

Group type: COMPARATOR
Intervention: Severe exacerbation
Number of subjects: 166
Study: 33983449

Group type: EXPERIMENTAL
Intervention: Intradialytic cycling (IDC) - 6-month programme, thrice weekly, moderate intensity cycling (RPE 12-14)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual care only (control group)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Intradialytic cycling (IDC)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Higher levels of physical activity and fitness
Number of subjects: 92
Study: 33541040

Group type: EXPERIMENTAL
Intervention: VR augmented RAGT
Number of subjects: 30

Group type: COMPARATOR
Intervention: RAGT only
Number of subjects: 30